Safety and Tolerability of N-Acetylcysteine in Cocaine-Dependent Individuals

REFERENCES

• Drug Abuse Warning Network. Washington, DC: Office of Applied Studies; 2001.
   Google Scholar
• Brust JC, Richter R. Stroke associated with cocaine abuse? New York State Journal of Medicine. 1977;77:1473–1475. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Schwartz KA, Cohen JA. Subarachnoid hemorrhage precipitated by cocaine snorting. Arch Neurol. 1984;41:705. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cregler LL, Mark H. Medical complications of cocaine abuse. N Eng J Med. 1986;315:1495–1500. [CSA]
   PubMed Web of Science ®Google Scholar
• Booth RE, Watters JK, Chitwood DD. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health. 1993;83:1144–1148. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Conaboy RP. Cocaine and Federal Sentencing Policy. Washington, DC: United States Sentencing Commission; 1995.
   Google Scholar
• McFarland K, Kalivas PW. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci. 2001;21:8655–8663. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Pierce RC, Bell K, Duffy P, et al. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci. 1996;16:1550–1560. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bell K, Duffy P, Kalivas PW. Context-specific enhancement of glutamate transmission by cocaine. Neuropsychopharmacology. 2000;23:335–344. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Reid MS, Berger SP. Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. Neuroreport. 1996;7:1325–1329. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Reid MS, Hsu KJ, Berger SP. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse. 1997;27:95–105. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Baker DA, Khroyan TV, O'Dell LE, , et al. Differential effects of intra-accumbens sulpiride on cocaine-induced locomotion and conditioned place preference. J Pharmacol Exp Ther. 1996;279:392–401. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mosby's Drug Consult. 14th ed. St. Louis, Mo.: Mosby; 2004: II-29–II-31.
   Google Scholar
• Grandjean EM, Berthet P, Ruffman R, , et al. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published, double-blind, placebo-controlled clinical trials. Clin Ther. 2000;22:209–221. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Smilkstein MJ, Knapp GL, Kulig KW, Rumak BH. Efficacy of oral N-acetylcysteine in treatment of acetaminophen overdose: analysis of the national multicenter study. N Eng J Med. 1998;319:1557–1562. [CSA]
   Web of Science ®Google Scholar
• Mucomyst [package insert]. Princeton, NJ: Bristol Meyers Squibb; 2001.
   Google Scholar
• Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C. Acetylcysteine for the prevention of contrast nephropathy: meta-analysis. Lancet. 2003;362:598–603. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Adair JC, Knoefel JE, Morgan. Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease. Neurology. 2001;57:1515–1517. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Miller LF, Rumack BH. Clinical safety of high oral doses of acetylcysteine. Semin Oncol. 1983;10:76–85. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kozer E, Koren G. Management of paracetamol overdose: current controversies. Drug Saf. 2001;24:503–512. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schmidt LE, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol. 2001;51:87–91. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hershkovitz E, Shorer Z, Levitas A, Tal A. Status epilepticus following intravenous N-acetylcysteine therapy. Israel Journal of Medical Science. 1996;32:1102–1104. [CSA]
   PubMedGoogle Scholar
• Mant TGK, Tempowski JH, Volans GN, Talbot JCC. Adverse reactions to acetylcysteine and effects of overdose. BMJ. 1984;289:217–219. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Death after N-acetylcysteine [Notes and News]. Lancet. 1984;1:1421. [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, , et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sobell MB, Sobell LC. Behavioral Treatment of Alcohol Problems. New York, NY: Plenum Press; 1978.
   Google Scholar
• Kampman KM, Volpicelli JR, McGinnis DE, et al. Reliability and validity of the cocaine selective severity scale. Addict Behav. 1998;23:449–461. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Holdiness MR. Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokineti. 1991;20:123–134. [CSA]
   Google Scholar